Amanote Research
Register
Sign In
Association of Paclitaxel Pharmacokinetics With the Development of Peripheral Neuropathy in Patients With Advanced Cancer
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-0298
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 2005
Authors
S. Mielke
Publisher
American Association for Cancer Research (AACR)
Related search
Regulatory Polymorphisms in -Tubulin IIa Are Associated With Paclitaxel-Induced Peripheral Neuropathy
Clinical Cancer Research
Cancer Research
Oncology
Peripheral Neuropathy in Patients With Psoriatic Arthritis
ScienceRise: Medical Science
Effect of Proprioceptive Training on Balance in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy
International Journal of Physiotherapy and Research
Safety and Pharmacokinetics of Motesanib in Combination With Panitumumab and Gemcitabine-Cisplatin in Patients With Advanced Cancer
Journal of Oncology
Oncology
Factors Influencing the Severity of Pain in Patients With Peripheral Diabetic Neuropathy
Asian Journal of Pharmaceutical and Clinical Research
Pharmacology
Pharmaceutical Science
Identifying Peripheral Neuropathy in Fall Patients With the Heat-Washout Method
Journal of Neurology and Neuromedicine
Incidence and Relative Risk of Peripheral Neuropathy in Cancer Patients Treated With Eribulin: A Meta-Analysis
Oncotarget
Oncology
Replication of Genetic Polymorphisms Reported to Be Associated With Taxane-Related Sensory Neuropathy in Patients With Early Breast Cancer Treated With Paclitaxel--Response
Clinical Cancer Research
Cancer Research
Oncology
Estrogen Deficiency Aggravates Paclitaxel-Induced Peripheral Neuropathy: Involvement of HMGB1
Proceedings for Annual Meeting of The Japanese Pharmacological Society
